The mission of the NIH PGRN is to advance our knowledge of the genetic basis for variable drug responses. Details...
The PGRN welcomes individuals, groups, or teams in pharmacogenetics human genetics, or pharmacology and related fields to apply for affiliate membership. Details...
Click on the acronym for each group to learn more about research goals and participating investigators. Click here to see all publications by PGRN members.
NWAP:
Pharmacogenetics in Rural and Underserved Populations
PI: Kenneth E. Thummel, Ph.D.,
Wylie Burke, M.D., Ph.D.
PAAR4Kids:
Pharmacogenomics of Anticancer Agents Research in Children
PI: Mary V. Relling, Pharm.D.
PEAR:
Pharmacogenomic Evaluation of Antihypertensive Responses
PI: Julie A. Johnson, Pharm.D.
PHAT:
Pharmacogenetics of Asthma Treatment
PI: Scott T. Weiss, M.D., M.S.,
Kelan G. Tantisira, M.D., M.P.H.
PPII:
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
PI: Richard M. Weinshilboum, M.D.
PAAR:
Pharmacogenetics of Anticancer Agents
PI: Mark J. Ratain, M.D.,
Nancy J. Cox, Ph.D.,
M. Eileen Dolan, Ph.D.
PAPI:
The Amish Pharmacogenomics of Anti-Platelet Intervention Study
PI: Alan R. Shuldiner, M.D.
PGBD:
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder
PI: John Kelsoe, M.D.
PNAT:
Pharmacogenetics of Nicotine Addiction and Treatment
PGRN-CGM:
Pharmacogenomics Research Network & Center for Genomic Medicine Global Alliance
PI: Kathleen M. Giacomini, Ph.D.,
Mark J. Ratain, M.D.,
Yusuke Nakamura, M.D.
WU-NGS:
Pharmacogenomics Research Network - Next Generation Sequencing
PI: Elaine R. Mardis, Ph.D.
PGPop:
PharmacoGenomic discovery and replication in very large patient POPulations
PI: Dan M. Roden, M.D.
UW-EXOME:
PGRN Network Resource: Human Exome Resequencing
PI: Deborah A. Nickerson, Ph.D.
PharmGKB:
PharmGKB: Catalyzing Research in Pharmacogenomics
PI: Russ B. Altman, M.D., Ph.D.
LCL:
Cell Based Resources for Pharmacogenomic Studies
PI: M. Eileen Dolan, Ph.D.
ELSI:
ELSI and Pharmacogenomics
PI: Ellen Clayton, J.D., M.D., M.S.
CREATE:
Functional Polymorphism Analysis in Drug Pathways
PI: Howard L. McLeod, Pharm.D.
COBRA:
Consortium on Breast Cancer Pharmacogenomics
PI: David A. Flockhart, M.D., Ph.D.
DIPN:
Design and Implementation of Pharmacogenetic Network
PI: Prakash M. Nadkarni, M.D.
PPRG:
UCLA Pharmacogenetics and Pharmacogenomics Research Group
PI: Julio Licinio, M.D.